Cardiovascular disease and bridging the diagnostic gap

John Kelly Wachira1, Tom P Stys

  • 1Department of Internal Medicine, Sanford School of Medicine of the University of South Dakota, USA.

Insights

Cardiovascular disease (CVD) is the leading global cause of death. This review examines CVD risk factors, assessment tools, and screening methods like coronary artery calcium (CAC) for early detection and prevention.

Area of Science:

  • Cardiology
  • Preventative Medicine
  • Medical Imaging

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality worldwide, presenting a significant global health challenge.
  • Coronary artery disease (CAD), the most common form of CVD, is the leading cause of death in the U.S. for both men and women.
  • Current preventative strategies heavily rely on risk stratification and early disease detection.

Purpose of the Study:

  • To conduct a comprehensive review of cardiovascular disease (CVD) risk factors.
  • To evaluate existing risk assessment and screening tools for early CVD detection.
  • To highlight the emerging role of coronary artery calcium (CAC) in improving cardiovascular event prediction.

Main Methods:

  • Literature review of CVD risk factors, assessment tools, and screening modalities.
  • Analysis of established risk calculators (e.g., Framingham Heart Score, PROCAM, SCORE).
  • Examination of non-invasive imaging techniques, specifically coronary artery calcium (CAC) scoring.

Main Results:

  • Traditional risk assessment tools provide multi-factorial absolute risk estimations for CVD.
  • Coronary artery calcium (CAC) has emerged as a promising non-invasive method for enhancing the prediction of future cardiovascular events.
  • The review synthesizes current knowledge on risk stratification and screening for early CVD detection.

Conclusions:

  • Accurate and sensitive risk assessment and screening tools are crucial for bridging the diagnostic gap in CVD.
  • Early detection of CVD through improved risk stratification and screening can facilitate timely intervention.
  • The ultimate goal is to reduce CVD incidence through early detection, risk factor modification, and prevention strategies.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K